Navigation Links
Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona

The state-of-the-art facility, located just outside of Phoenix, Arizona, will serve as a unique learning environment for the professional development and educational advancement of Grifols' employees.

GLENDALE, Ariz., Jan. 28 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, inducted its first class of students to the Grifols Academy of Plasmapheresis in Glendale, Arizona. The Academy is an 8,500 square foot facility adjacent to a fully operational plasma donor facility that will serve as the Company's central location for employee education, training and development. Grifols' investment in the Academy and adjacent plasma donor facility brings new jobs and economic growth to the area while offering advanced education and career development for Grifols' employees.

Employees admitted to the Academy have the opportunity to pursue learning in a broad range of disciplines. "The primary purpose of the Academy is not to provide training on plasma collection procedures and donor center operations," commented Academy Chairman Eduardo Herrero. "Rather, the goal is to provide our already highly skilled employees with an even broader context and deeper understanding of human health, ethics and science, as they relate to plasmapheresis," continued Herrero. Plasmapheresis is a process for obtaining human plasma that was developed by Grifols in 1951, and has given rise to the large-scale production of plasma therapies to treat hundreds of thousands of individuals with rare and often life-threatening diseases and conditions.

The Academy is chaired by an Academic Review Board responsible for establishing curriculum guidelines and educational achievement standards. "The learning that will take place at the Academy will benefit the students not only in their daily work, but also in their long-term personal and career development," said Marilyn Rosa Bray, MD, one of the Academy Board members and Medical Director for Biomat USA, one of Grifols' plasma divisions. Examples of some Academy course offerings include: Principles of Quality and Ethics, Plasma Therapies Today and in the Future, Introduction to Immunology and The Anatomy and Physiology of the Cardiovascular System.

The Academy is equipped with advanced technology classrooms and an interactive learning laboratory. In addition, the Academy houses two large conference rooms and an on-site gallery that showcases the history and importance of plasmapheresis in healthcare. The curriculum is delivered using a combination of classroom instruction, hands-on lab activities, goal-based scenarios and computer e-learning modules. Academy educators include representatives from Grifols' senior management, third-party experts and guest lecturers from industry and academia.

Joining Grifols for the inauguration of the Academy will be His Excellency Jorge Dezcallar, Ambassador to the US from the Kingdom of Spain, distinguished representatives from the Spanish Medicines Agency and the Department of Health of the Catalonia Autonomous Government, representatives from local and national patient organizations that rely on plasma medicines, Arizona state and local elected officials, as well as other guests and experts in the field of plasmapheresis.

About Grifols

Grifols SA (Grifols) is a global healthcare company founded in 1940 in Barcelona, Spain. Today Grifols products and services are provided in more than 90 countries around the world. Grifols specializes in the production of plasma therapies to treat a variety of rare and often life-threatening diseases and conditions. Grifols operates 80 plasma donor centers throughout the US and has manufacturing and testing facilities located in Barcelona, Spain, Austin, Texas, and Los Angeles, California. For more information about Grifols please visit

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries
2. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
3. AMA Inaugurates Dr. Nancy Nielsen as President
4. Sierra Tucson Pain Management Program Awarded Pain Program Accreditation by the American Academy of Pain Management For Treatment of Chronic Pain
5. Academy of General Dentistry Partners with Colgate-Palmolive
6. American Academy of Dermatology Issues Statement on FDA Report to Congress About Labeling Information on Indoor Tanning Devices
7. Fresh from Its 2008 Success, EDI Training Academy Expands into 2009 with 20 New Seminars and an EDI Health Care Best Practices Course
8. Jerry Lewis to Receive Prestigious Award From Motion Picture Academy
9. Melanoma Foundation of New England Wins Gold Triangle Award From the American Academy of Dermatology
10. Pharmacy Benefits Academy Set for 2009
11. American Academy of Dermatology Issues Position Statement on Vitamin D
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... N.J. , Dec. 1, 2015 ... held in San Francisco, CA ... solutions to the coronary marketplace. During a satellite ... in Stent Design to Minimize Restenosis", a renowned ... currently available Medinol NIRxcell™ CoCr Coronary Stent System ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
(Date:12/1/2015)...  InCarda Therapeutics, Inc. (InCarda), a privately-held biopharmaceutical company ... cardiovascular conditions via the inhalation route, today announced that ... Australia . InCarda is planning to undertake its ... in the first half of 2016. The company ... Adelaide and Melbourne.  In addition, ...
Breaking Medicine Technology: